MRI and cerebrospinal fluid biomarkers for predicting progression to Alzheimer's disease in patients with mild cognitive impairment: a diagnostic accuracy study

OBJECTIVES: To assess the incremental value of MRI and cerebrospinal fluid (CSF) analysis after a short memory test for predicting progression to Alzheimer's disease from a pragmatic clinical perspective. DESIGN: Diagnostic accuracy study in a multicentre prospective cohort study. SETTING: Alzh...

Descripción completa

Detalles Bibliográficos
Autores principales: Richard, Edo, Schmand, Ben A, Eikelenboom, Piet, Van Gool, Willem A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2013
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3686215/
https://www.ncbi.nlm.nih.gov/pubmed/23794572
http://dx.doi.org/10.1136/bmjopen-2012-002541

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3686215/
https://www.ncbi.nlm.nih.gov/pubmed/23794572
http://dx.doi.org/10.1136/bmjopen-2012-002541

Ejemplares similares